Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimenDELAUGERRE, Constance; CHARREAU, Isabelle; BRAUN, Josephine et al.AIDS (London). 2010, Vol 24, Num 15, pp 2391-2395, issn 0269-9370, 5 p.Article

Genotypic resistance analyses in nucleoside-pretreated patients failing an indinavir containing regimen: results from a randomized comparative trial: (Novavir ANRS 073)DESCAMPS, Diane; JOLY, Véronique; FLANDRE, Philippe et al.Journal of clinical virology. 2005, Vol 33, Num 2, pp 99-103, issn 1386-6532, 5 p.Article

Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial)JOLY, Véronique; FLANDRE, Philippe; ABOULKER, Jean-Pierre et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 6, pp 1906-1913, issn 0066-4804Article

Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trialJOLY, Véronique; FLANDRE, Philippe; MEIFFREDY, Vincent et al.AIDS (London). 2002, Vol 16, Num 18, pp 2447-2454, issn 0269-9370, 8 p.Article

Presence of Lamivudine or Emtricitabine Is Associated with Reduced Emergence of Nonnucleoside Reverse Transcriptase Inhibitor Mutations in an Efavirenz-Based Intermittent Antiretroviral Treatment RegimenTRANCART, Stéphanie; CHARREAU, Isabelle; MARCHOU, Bruno et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 3, pp 1655-1657, issn 0066-4804, 3 p.Article

Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trialGALLIEN, Sébastien; BRAUN, Josephine; ABOULKER, Jean-Pierre et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 9, pp 2099-2106, issn 0305-7453, 8 p.Article

A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children : the PERA (PENTA 8) TrialGREEN, Hannah; GIBB, Diana M; ABOULKER, Jean-Pierre et al.Antiviral therapy (London). 2006, Vol 11, Num 7, pp 857-867, issn 1359-6535, 11 p.Article

Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patientsLEVY, Yves; GAHERY-SEGARD, Hanne; DELFRAISSY, Jean-Francois et al.AIDS (London). 2005, Vol 19, Num 3, pp 279-286, issn 0269-9370, 8 p.Article

Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adultsDURIE, Christine; LAUNAY, Odile; MEIFFREDY, Vincent et al.AIDS (London). 2006, Vol 20, Num 7, pp 1039-1049, issn 0269-9370, 11 p.Article

Experience using MedDRA for global events coding in HIV clinical trialsTONEATTI, Christine; SAÏDI, Yacine; MEIFFREDY, Vincent et al.Contemporary clinical trials. 2006, Vol 27, Num 1, pp 13-22, issn 1551-7144, 10 p.Article

Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled TrialLAUNAY, Odile; DESAINT, Corinne; AJANA, Faiza et al.The Journal of infectious diseases. 2011, Vol 204, Num 1, pp 124-134, issn 0022-1899, 11 p.Article

Interleukin-2 before Antiretroviral Therapy in Patients with HIV Infection: A Randomized Trial (ANRS 119)MOLINA, Jean-Michel; LEVY, Yves; JEANBLANC, François et al.The Journal of infectious diseases. 2009, Vol 200, Num 2, pp 206-215, issn 0022-1899, 10 p.Article

Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048-079 Trials)DURIER, Christine; CAPITANT, Catherine; ABOULKER, Jean-Pierre et al.AIDS (London). 2007, Vol 21, Num 14, pp 1887-1897, issn 0269-9370, 11 p.Article

Contribution of cellular HIV-1 DNA quantification to the efficacy analysis of antiretroviral therapy : A randomized comparison of 2 regimens, including 3 drugs from 2 or 3 classes (TRIANON, ANRS 081)MORAND-JOUBERT, Laurence; MARCELLIN, Fabienne; LAUNAY, Odile et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 38, Num 3, pp 268-276, issn 1525-4135, 9 p.Article

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patientsTABURET, Anne-Marie; PIKETTY, Christophe; CHAZALLON, Corine et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 2091-2096, issn 0066-4804, 6 p.Article

Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trialLEVY, Yves; DURIER, Christine; GOUJARD, Cécile et al.AIDS (London). 2003, Vol 17, Num 3, pp 343-351, issn 0269-9370, 9 p.Article

HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4⁺ T-cell counts and antiviral responseIZOPET, Jacques; MARCHOU, Bruno; CHARREAU, Isabelle et al.Antiviral therapy (London). 2008, Vol 13, Num 4, pp 537-545, issn 1359-6535, 9 p.Article

Acceptability of an on-demand pre-exposure HIV prophylaxis trial among men who have sex with men living in FranceLORENTE, Nicolas; FUGONA, Lionel; CARRIERIA, Maria Patrizia et al.AIDS Care (Print). 2012, Vol 24, Num 3-4, pp 468-477, issn 0954-0121, 10 p.Article

Maternal Immune Response and Neonatal Seroprotection From a Single Dose of a Monovalent Nonadjuvanted 2009 Influenza A(H1N1) Vaccine: A Single-Group TrialTSATSARIS, Vassilis; CAPITANT, Catherine; JACQZ-AIGRAIN, Evelyne et al.Annals of internal medicine. 2011, Vol 155, Num 11, pp 733-741, issn 0003-4819, 9 p.Article

Pharmacogenetics of Toxicity, Plasma Trough Concentration and Treatment Outcome with Nevirapine-Containing Regimen in Anti-Retroviral-Naïve HIV-Infected Adults: An Exploratory Study of the TRIANON ANRS 081 TrialGOZALO, Claire; GERARD, Laurence; VERSTUYFT, Céline et al.Basic & clinical pharmacology & toxicology (Print). 2011, Vol 109, Num 6, pp 513-520, issn 1742-7835, 8 p.Article

Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trialSALMON-CERON, Dominique; DURIER, Christine; ABOULKER, Jean-Pierre et al.AIDS (London). 2010, Vol 24, Num 14, pp 2211-2223, issn 0269-9370, 13 p.Article

Intermittent antiretroviral therapy in patients with controlled HIV infectionMARCHOU, Bruno; TANGRE, Philippe; CHARREAU, Isabelle et al.AIDS (London). 2007, Vol 21, Num 4, pp 457-466, issn 0269-9370, 10 p.Article

Structured treatment interruptions in primary HIV-1 infection : The ANRS 100 PRIMSTOP trialHOEN, Bruno; FOURNIER, Isabelle; ABOULKER, Jean-Pierre et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 40, Num 3, pp 307-316, issn 1525-4135, 10 p.Article

Successful implementation of a low-cost method for enumerating CD4⁺ T lymphocytes in resource-limited settings: the ANRS 12-26 studyDIAGBOUGA, Serge; CHAZALLON, Corine; WEISS, Lawrence et al.AIDS (London). 2003, Vol 17, Num 15, pp 2201-2208, issn 0269-9370, 8 p.Article

Costs of Intermittent Versus Continuous Antiretroviral Therapy in Patients With Controlled HIV Infection : A Substudy of the ANRS 106 Window TrialCHARREAU, Isabelle; JEANBLANC, Grégoire; TANGRE, Philippe et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 4, pp 416-421, issn 1525-4135, 6 p.Conference Paper